Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

High Risk Multiple Myeloma Survival w/ Dr. Rafael Fonseca of Mayo Clinic

  • Broadcast in Health
  • 0 comments
CureTalks

CureTalks

×  

Follow This Show

If you liked this show, you should follow CureTalks.
h:350019
s:6083919
archived

We are talking to Dr. Rafael Fonseca on our myeloma talk series this April.

Dr. Fonseca is currently deputy director, Mayo Clinic Cancer Center, Getz Family Professor of Cancer and professor of medicine, Mayo Clinic College of Medicine, as well as site director, hematological malignancies, Mayo Clinic, Scottsdale, Arizona. Dr. Fonseca is a fellow of the International Society of Hematology and is board certified in internal medicine, medical oncology, and hematology. In addition, he holds professional memberships in the American Association of Cancer Research, American Society of Hematology, American Society of Clinical Oncology, and the Mexican Society of Internal Medicine, among others. Dr. Fonseca is a reviewer for numerous journals including American Journal of Hematology, American Journal of Medicine, Blood, British Journal of Haematology, Circulation, Hematologica, International Journal of Cancer, Journal of Clinical Oncology, Leukemia, New England Journal of Medicine, and is on the editorial board of Molecular Cancer Therapeutics, and Leukemia. He has written more than 100 peer-reviewed articles, book chapters, and abstracts. Dr. Fonseca has developed an expertise in the management of plasma cell disorders. His clinical practice is primarily composed of patients with multiple myeloma, primary amyloidosis, and monoclonal gammopathy.

Comments

 comments